Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2020 at "ChemMedChem"
DOI: 10.1002/cmdc.201900722
Abstract: Abstract: A major challenge of targeted cancer therapy is the selection for drug‐resistant mutations in tumor cells leading to loss of treatment effectiveness. p97/VCP is central regulator of protein homeostasis and a promising anticancer target…
read more here.
Keywords:
p97 inhibitors;
allosteric p97;
atp competitive;
competitive p97 ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c02192
Abstract: Mutations in MEK1/2 have been described as a resistance mechanism to BRAF/MEK inhibitor treatment. We report the discovery of a novel ATP-competitive MEK1/2 inhibitor with efficacy in wildtype (WT) and mutant MEK12 models. Starting from…
read more here.
Keywords:
selective mek1;
inhibitor;
mek1 inhibitor;
atp competitive ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "ACS chemical biology"
DOI: 10.1021/acschembio.7b00116
Abstract: PF-956980 has been used previously as a JAK3-selective chemical probe in numerous cell-based experiments. Here, we report that not only is PF-956980 a pan-JAK ATP-competitive inhibitor but it also causes selective reduction of endogenous JAK2…
read more here.
Keywords:
atp competitive;
jak2 jak3;
pan jak;
jak2 ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2020 at "Nature Communications"
DOI: 10.1038/s41467-020-19974-5
Abstract: Inositol-Requiring Enzyme 1 (IRE1) is an essential component of the Unfolded Protein Response. IRE1 spans the endoplasmic reticulum membrane, comprising a sensory lumenal domain, and tandem kinase and endoribonuclease (RNase) cytoplasmic domains. Excess unfolded proteins…
read more here.
Keywords:
kinase front;
kinase;
atp competitive;
rnase ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2022 at "Nature communications"
DOI: 10.1038/s41467-022-29655-0
Abstract: The AKT kinases have emerged as promising therapeutic targets in oncology and both allosteric and ATP-competitive AKT inhibitors have entered clinical investigation. However, long-term efficacy of such inhibitors will likely be challenged by the development…
read more here.
Keywords:
allosteric atp;
resistance;
atp competitive;
akt inhibitors ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Biochemical Society Transactions"
DOI: 10.1042/bst20190777
Abstract: Aberrant activation of the PI3K pathway is one of the commonest oncogenic events in human cancer. AKT is a key mediator of PI3K oncogenic function, and thus has been intensely pursued as a therapeutic target.…
read more here.
Keywords:
atp competitive;
inhibitors aktion;
aktion atp;
competitive allosteric ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz268.085
Abstract: Abstract Background A subgroup of MEK1 mutations in human tumors were recently described as RAF- and phosphorylation independent and as insensitive to currently clinically used allosteric MEK inhibitors. We established a novel cell line that…
read more here.
Keywords:
inhibitor;
mek inhibitor;
atp competitive;
mek ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Science Advances"
DOI: 10.1126/sciadv.abo0696
Abstract: ATP-competitive inhibitors are currently the largest class of clinically approved drugs for protein kinases. By targeting the ATP-binding pocket, these compounds block the catalytic activity, preventing substrate phosphorylation. A problem with these drugs, however, is…
read more here.
Keywords:
binding cooperativity;
competitive inhibitors;
conformational entropy;
substrate binding ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "F1000Research"
DOI: 10.12688/f1000research.108761.2
Abstract: B-Raf is a protein kinase participating to the regulation of many biological processes in cells. Several studies have demonstrated that this protein is frequently upregulated in human cancers, especially when it bears activating mutations. In…
read more here.
Keywords:
innovative mechanisms;
competitive inhibitors;
raf;
raf inhibitors ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "PLoS ONE"
DOI: 10.1371/journal.pone.0225132
Abstract: P21-activated kinases (PAKs) are serine/threonine protein kinases that are subdivided into two groups on the basis of their domain architecture: group-I (PAK1–3) and group-II (PAK4–6). PAKs are considered as attractive drug targets that play vital…
read more here.
Keywords:
p21 activated;
basis;
atp competitive;
family members ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Acta chimica Slovenica"
DOI: 10.17344/acsi.2019.4880
Abstract: Binary (nucleotide-protein dimer and hexamer complexes) and ternary (nucleotide-protein-inhibitor complexes) p97 complexes were subjected to molecular dynamics simulations in an attempt to further our understanding of the p97 protein oligomer domain stability and, more importantly,…
read more here.
Keywords:
allosteric atp;
simulations p97;
dynamics simulations;
atp competitive ... See more keywords